Skip to main content
Hikal Ltd. logo

Hikal Ltd. — Investor Relations & Filings

Ticker · HIKAL ISIN · INE475B01022 LEI · 335800OLTGHHYZWTF859 BSE.NS Manufacturing
Filings indexed 737 across all filing types
Latest filing 2020-03-06 Regulatory Filings
Country IN India
Listing BSE.NS HIKAL

About Hikal Ltd.

https://www.hikal.com

Hikal Ltd. provides solutions across the life sciences value chain, specializing in the development and manufacturing of active ingredients, intermediates, and formulations. The company operates through two primary business segments: Pharmaceuticals and Crop Protection. In the pharmaceutical division, it focuses on the production of Active Pharmaceutical Ingredients (APIs) and advanced intermediates for various therapeutic areas. The crop protection segment involves the contract manufacturing of pesticides, herbicides, and fungicides for global agrochemical leaders. Hikal offers comprehensive Contract Research and Manufacturing Services (CRAMS), leveraging its research and development capabilities to support clients from early-stage development to commercial-scale production. Its facilities adhere to international quality standards, maintaining a strong track record of regulatory compliance with global health authorities.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document text is extremely short (64 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any detailed information. Given the lack of content, this cannot be classified as a full report or detailed filing. It is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous or insufficient content filings.
2020-03-06 English
Record Date
Regulatory Filings
2020-02-05 English
Dividend
Interim / Quarterly Report Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding unaudited financial results for the quarter and nine months ended 31 December 2019. It includes detailed financial data, an independent auditor's review report pursuant to SEBI regulations, and declaration of an interim dividend with record and payment dates. The presence of unaudited financial results with substantive financial data and analysis, along with the auditor's review report, indicates this is a quarterly/interim financial report. The document is about the financial results for a period shorter than a full fiscal year and contains actual financial statements and analysis, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2020
2020-02-05 English
Financial Result Updates
Regulatory Filings
2020-02-05 English
Updates
Regulatory Filings Classification · 100% confidence The document text is extremely short (68 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any announcement text. Given the lack of any meaningful information, this document does not fit any specific report category and defaults to the fallback category for miscellaneous filings.
2020-01-27 English
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 100% confidence The document text is extremely short (68 characters) and contains no substantive content, financial data, or any identifiable information related to company filings. It only mentions an omitted picture and empty sections. There is no indication of any report, announcement, or filing type. Given the lack of content, the document cannot be classified as any specific report or announcement. According to the rules, such documents default to the fallback category Regulatory Filings (RNS).
2020-01-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.